Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,072 | -27,494 | -18,243 | -7,827 | -2,447 |
| Depreciation Amortization | 434 | 1,634 | 1,221 | 752 | 411 |
| Accounts receivable | 278 | -902 | -452 | -1,509 | -1,433 |
| Other Working Capital | -3,345 | -95 | -2,779 | -3,288 | -4,363 |
| Other Operating Activity | 4,141 | 3,283 | 1,448 | -29 | 428 |
| Operating Cash Flow | $-10,564 | $-23,574 | $-18,805 | $-11,901 | $-7,404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131 | -610 | -473 | -348 | -191 |
| Purchase Of Investment | N/A | -330 | -330 | -330 | N/A |
| Other Investing Activity | 0 | -350 | -350 | 0 | 0 |
| Investing Cash Flow | $-131 | $-1,290 | $-1,153 | $-678 | $-191 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,000 | 20,000 | 20,000 | N/A |
| Debt Repayment | 0 | -5,454 | -5,454 | -5,454 | -652 |
| Common Stock Issued | 674 | 52,614 | 24,364 | 24,356 | 18,414 |
| Other Financing Activity | 0 | -2,482 | -1,077 | -1,077 | -337 |
| Financing Cash Flow | $674 | $64,678 | $37,833 | $37,825 | $17,425 |
| Beginning Cash Position | 52,668 | 12,854 | 12,854 | 12,854 | 12,854 |
| End Cash Position | 42,647 | 52,668 | 30,729 | 38,100 | 22,684 |
| Net Cash Flow | $-10,021 | $39,814 | $17,875 | $25,246 | $9,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,564 | -23,574 | -18,805 | -11,901 | -7,404 |
| Capital Expenditure | -131 | -610 | -473 | -348 | -191 |
| Free Cash Flow | -10,695 | -24,184 | -19,278 | -12,249 | -7,595 |